Locations:

Tag: idiopathic pulmonary fibrosis (IPF)

February 10, 2022/Pulmonary/Research

Context Matters: How the Paradigm for Studying Pulmonary Fibrosis is Changing

Research from three pulmonologists is shining light on mechanotransduction and ECM signal processing in ways that could lead to new therapeutic options

650×450-Interstitial-Lung-Disease-Outcomes

November 19, 2020/Pulmonary/Interstitial Lung Disease

Does Accurate Diagnosis Still Matter for Interstitial Lung Disease?

Multidisciplinary approach can uncover unsuspected diagnoses

August 24, 2020/Pulmonary

Clinical Collaboration Leads to Multi-Organ Transplant Success Story

A multidisciplinary approach to a unique transplant case

18-PUL-4645-Tolle-Hero-Image-650x450pxl[5]

September 26, 2018/Pulmonary/Interstitial Lung Disease

How to Treat Idiopathic Pulmonary Fibrosis

An overview of available treatment modalities

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-PUL-4644-Tolle-Hero-Image-650x450pxl_02

September 12, 2018/Primary Care

A Diagnostic Algorithm for Idiopathic Pulmonary Fibrosis

When primary care physicians should suspect IPF

August 30, 2018/Primary Care

Idiopathic Pulmonary Fibrosis: What PCPs Need To Know

An overview of IPF for primary care physicians

September 23, 2015/Pulmonary/News & Insight

Pirfenidone and Nintedanib: Novel Agents in the Treatment of Idiopathic Pulmonary Fibrosis

FDA-approved drugs offer hope for devastating lung disease

BackPage 1 of 1Next